Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7747)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2017 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim SM, George B, Alcivar-Franco D, Campbell CL, Charnigo R, Delisle B, Hundley J, Darrat Y, Morales G, Elayi SC, Bailey AL. QT prolongation is associated with increased mortality in end stage liver disease. World J Cardiol 2017; 9(4): 347-354 [PMID: 28515853 DOI: 10.4330/wjc.v9.i4.347] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v9/i4/347.htm |
| Number | Citing Articles |
| 1 |
Abhinav Bhardwaj, Sandeep Joshi, Ruby Sharma, Sakshi Bhardwaj, Rishabh Agrawal, Nitin Gupta. QTc prolongation in patients of cirrhosis and its relation with disease severity: An observational study from a rural teaching hospital. Journal of Family Medicine and Primary Care 2020; 9(6): 3020 doi: 10.4103/jfmpc.jfmpc_341_20
|
| 2 |
Yousef H Darrat, Aiman Smer, Claude-Samy Elayi, Gustavo X Morales, Fahad Alqahtani, Mohamad Alkhouli, John Catanzaro, Jignesh Shah, Mohsin Salih. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World Journal of Cardiology 2020; 12(7): 342-350 doi: 10.4330/wjc.v12.i7.342
|
| 3 |
Csaba Matyas, György Haskó, Lucas Liaudet, Eszter Trojnar, Pal Pacher. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nature Reviews Cardiology 2021; 18(2): 117 doi: 10.1038/s41569-020-0433-5
|
| 4 |
Devon Flaherty, Sang Kim, Jeron Zerillo, Chang Park, Thomas Joseph, Bryan Hill, Hung-Mo Lin, Jiawen Li, Carlyle Hamsher, Menachem M. Weiner, Samuel DeMaria. Preoperative QTc Interval is Not Associated With Intraoperative Cardiac Events or Mortality in Liver Transplantation Patients. Journal of Cardiothoracic and Vascular Anesthesia 2019; 33(4): 961 doi: 10.1053/j.jvca.2018.06.002
|
| 5 |
Min Ou, Yin Tian, Guoqiang Zhuang, Ying Peng. QTc interval prolongation in liver cirrhosis with upper gastrointestinal bleeding. Medicina Clínica (English Edition) 2021; 156(2): 68 doi: 10.1016/j.medcle.2020.06.032
|
| 6 |
Paolo COSTA, Gian M. ROSA, Gianni TESTINO, Ulrico DORIGHI, Italo PORTO. Liver involvement in presence of heart disease and heart involvement in presence of liver disease: a conundrum. Minerva Gastroenterology 2024; 70(3) doi: 10.23736/S2724-5985.23.03589-1
|
| 7 |
Sanjana Nagraj, Spyros Peppas, Maria Gabriela Rubianes Guerrero, Damianos G Kokkinidis, Felipe I Contreras-Yametti, Sandhya Murthy, Ulrich P Jorde. Cardiac risk stratification of the liver transplant candidate: A comprehensive review. World Journal of Transplantation 2022; 12(7): 142-156 doi: 10.5500/wjt.v12.i7.142
|
| 8 |
Braden Vogt, Antony F. Chu. Cardiovascular Considerations in Patients with Liver Cirrhosis. Digestive Disease Interventions 2022; 6(02): 155 doi: 10.1055/s-0042-1745860
|
| 9 |
Konstantin Kazankov, Henrik Kjaerulf Jensen, Hugh Watson, Hendrik Vilstrup, Mauro Bernardi, Peter Jepsen. QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites. Scandinavian Journal of Gastroenterology 2019; 54(11): 1376 doi: 10.1080/00365521.2019.1677767
|
| 10 |
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. β-blockers in advanced cirrhosis: More friend than enemy. Clinical and Molecular Hepatology 2021; 27(3): 425 doi: 10.3350/cmh.2020.0234
|
| 11 |
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, Marco Rossato. Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells 2020; 9(3): 567 doi: 10.3390/cells9030567
|
| 12 |
Shadi Baniasadi, Behrooz Farzanegan, Zeinab Hosseinpoor, Seyyed R Seyyedi, Mehdi Rajabi. An Observational Study of QTc Prolongation in Critically Ill Patients: Identification of Incidence and Predictors
. Indian Journal of Critical Care Medicine 2020; 24(4): 270 doi: 10.5005/jp-journals-10071-23411
|
| 13 |
Marium Kanwal, Waqar Hussain, Aqsa Soomro, Razia Aijaz, Sumon Khalique, Maliha Sadaf. Prevalence of Prolonged QT Interval In Patients With Chronic Liver Disease. Pakistan Journal of Health Sciences 2022; : 162 doi: 10.54393/pjhs.v3i05.258
|
| 14 |
Min Ou, Yin Tian, Guoqiang Zhuang, Ying Peng. QTc interval prolongation in liver cirrhosis with upper gastrointestinal bleeding. Medicina Clínica 2021; 156(2): 68 doi: 10.1016/j.medcli.2020.06.059
|
| 15 |
Mohammad Hosein Yazdanpanah, Mohammad Mehdi Naghizadeh, Sepideh Sayyadipoor, Mojtaba Farjam. The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study. BMC Cardiovascular Disorders 2022; 22(1) doi: 10.1186/s12872-022-02502-2
|
| 16 |
J. Shah, E. Shao. Encyclopedia of Cardiovascular Research and Medicine. 2018; : 514 doi: 10.1016/B978-0-12-809657-4.11046-4
|
| 17 |
Vasileios Periklis Papadopoulos, Konstantinos Mimidis. Corrected QT interval in cirrhosis: A systematic review and meta-analysis. World Journal of Hepatology 2023; 15(9): 1060-1083 doi: 10.4254/wjh.v15.i9.1060
Abstract(501) |
Core Tip(363) |
Full Article(HTML)(1524)
|
Full Article with Cover (PDF)-5519K(88)
|
Full Article (Word)-1339K(36)
|
Audio-798K(5)
|
Peer-Review Report-215K(51)
|
Answering Reviewers-187K(57)
|
Supplementary Material-100K(59)
|
Full Article (PDF)-4671K(124)
|
Full Article (XML)-285K(47)
|
Times Cited (1)
|
Total Visits (5445)
|
Open
|
| 18 |
|
| 19 |
William Lee, Bert Vandenberk, Satish R. Raj, Samuel S. Lee. Prolonged QT Interval in Cirrhosis: Twisting Time?. Gut and Liver 2022; 16(6): 849 doi: 10.5009/gnl210537
|
| 20 |
So Yeon Kim, Kang Ho Kim, Jan M. Schilling, Joseph Leem, Mehul Dhanani, Brian P. Head, David M. Roth, Alice E. Zemljic-Harpf, Hemal H. Patel. Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(3): G531 doi: 10.1152/ajpgi.00346.2019
|
| 21 |
Nicholas Scalzo, Mehtap Canastar, Edward Lebovics. Part 1: Disease of the Heart and Liver. Cardiology in Review 2022; 30(3): 111 doi: 10.1097/CRD.0000000000000379
|
| 22 |
Elias Tsiompanidis, Spyros I Siakavellas, Anastasios Tentolouris, Ioanna Eleftheriadou, Stamatia Chorepsima, Anastasios Manolakis, Konstantinos Oikonomou, Nikolaos Tentolouris. Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity. World Journal of Gastrointestinal Pathophysiology 2018; 9(1): 28-36 doi: 10.4291/wjgp.v9.i1.28
|
| 23 |
Manfred Hauben, Robert Reynolds, Patrick Caubel. Deconstructing the Pharmacovigilance Hype Cycle. Clinical Therapeutics 2018; 40(12): 1981 doi: 10.1016/j.clinthera.2018.10.021
|
| 24 |
Seung Hyun Kim, Jae Geun Lee, Hyang Mi Ju, SuYoun Choi, Hyukjin Yang, Bon-Nyeo Koo. Propofol prevents further prolongation of QT interval during liver transplantation. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-08592-4
|
| 25 |
Hamid Reza Moheimani, Taghi Amiriani, Ali Mohammad Alizadeh, Yahya Jand, Delaram Shakiba, Parham Sayyah Ensan, Fatemeh Jafarzadeh, Maryam Rajaei, Ayesheh Enayati, Mona Pourabouk, Shahriar Aliazadeh, Amir Hoshang Pourkhani, Zohreh Mazaheri, Mohammad Ali Zeyghami, Ahmadreza Dehpour, Vahid Khori. Preconditioning and anti-apoptotic effects of Metformin and Cyclosporine-A in an isolated bile duct-ligated rat heart. European Journal of Pharmacology 2021; 893: 173807 doi: 10.1016/j.ejphar.2020.173807
|
| 26 |
Association between cardiac dysfunction, arrhythmias and chronic liver diseases: A narrative review. Trends in Anaesthesia and Critical Care 2020; 32: 4 doi: 10.1016/j.tacc.2020.03.003
|
| 27 |
Hongqun Liu, Jwan A. Naser, Grace Lin, Samuel S. Lee. Cardiomyopathy in cirrhosis: From pathophysiology to clinical care. JHEP Reports 2024; 6(1): 100911 doi: 10.1016/j.jhepr.2023.100911
|
| 28 |
Yousef H Darrat, Aiman Smer, Claude-Samy Elayi, Gustavo X Morales, Fahad Alqahtani, Mohamad Alkhouli, John Catanzaro, Jignesh Shah, Mohsin Salih. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World Journal of Cardiology 2020; 12(7): 342-350 doi: 10.4330/wjc.v12.i7.342
|
| 29 |
Alireza Moaref, Mahmood Zamirian, Hamed Mirzaei, Amin Attar, Elham Nasrollahi, Yaser Bahramvand. Myocardial contractile dispersion: A new marker for the severity of cirrhosis?. Journal of Cardiovascular and Thoracic Research 2019; 11(2): 147 doi: 10.15171/jcvtr.2019.25
|
| 30 |
Zihao Wang, Rongkai Qian, Yanhua Wang, Lingfei Mo, Bomiao Ju, Nan Hu, Pei Wang, Lan He, Jing Wang. QTc interval prolongation in the patients with primary biliary cholangitis. Annals of Noninvasive Electrocardiology 2022; 27(1) doi: 10.1111/anec.12925
|